147 related articles for article (PubMed ID: 33608772)
41. O-linked N-acetylglucosamine modification of insulin receptor substrate-1 occurs in close proximity to multiple SH2 domain binding motifs.
Klein AL; Berkaw MN; Buse MG; Ball LE
Mol Cell Proteomics; 2009 Dec; 8(12):2733-45. PubMed ID: 19671924
[TBL] [Abstract][Full Text] [Related]
42. O-GlcNAcylation Quantification of Certain Protein by the Proximity Ligation Assay and
Song J; Liu C; Wang X; Xu B; Liu X; Li Y; Xia J; Li Y; Zhang C; Li D; Sun H
ACS Chem Biol; 2021 Jun; 16(6):1040-1049. PubMed ID: 34105348
[TBL] [Abstract][Full Text] [Related]
43. Effect of xixin decoction on O-linked N-acetylglucosamine glycosylation of tau proteins in rat brain with sporadic Alzheimer disease.
Diwu Y; Tian J; Shi J
J Tradit Chin Med; 2013 Jun; 33(3):367-72. PubMed ID: 24024334
[TBL] [Abstract][Full Text] [Related]
44. IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1.
Suzuki H; Moldoveanu Z; Hall S; Brown R; Vu HL; Novak L; Julian BA; Tomana M; Wyatt RJ; Edberg JC; Alarcón GS; Kimberly RP; Tomino Y; Mestecky J; Novak J
J Clin Invest; 2008 Feb; 118(2):629-39. PubMed ID: 18172551
[TBL] [Abstract][Full Text] [Related]
45. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity.
Suzuki H; Fan R; Zhang Z; Brown R; Hall S; Julian BA; Chatham WW; Suzuki Y; Wyatt RJ; Moldoveanu Z; Lee JY; Robinson J; Tomana M; Tomino Y; Mestecky J; Novak J
J Clin Invest; 2009 Jun; 119(6):1668-77. PubMed ID: 19478457
[TBL] [Abstract][Full Text] [Related]
46. O-linked N-acetylglucosamine is present on the extracellular domain of notch receptors.
Matsuura A; Ito M; Sakaidani Y; Kondo T; Murakami K; Furukawa K; Nadano D; Matsuda T; Okajima T
J Biol Chem; 2008 Dec; 283(51):35486-95. PubMed ID: 18948267
[TBL] [Abstract][Full Text] [Related]
47. Tyrosyl motif in amelogenins binds N-acetyl-D-glucosamine.
Ravindranath RM; Moradian-Oldak J; Fincham AG
J Biol Chem; 1999 Jan; 274(4):2464-71. PubMed ID: 9891017
[TBL] [Abstract][Full Text] [Related]
48. Identification of O-linked N-acetylglucosamine modification of ankyrinG isoforms targeted to nodes of Ranvier.
Zhang X; Bennett V
J Biol Chem; 1996 Dec; 271(49):31391-8. PubMed ID: 8940148
[TBL] [Abstract][Full Text] [Related]
49. O-GlcNAcylation of the human epidermal growth factor receptor.
Stateva SR; Villalobo A
Org Biomol Chem; 2015 Aug; 13(30):8196-204. PubMed ID: 26108188
[TBL] [Abstract][Full Text] [Related]
50. O-glycosylation of the nuclear forms of Pax-6 products in quail neuroretina cells.
Lefebvre T; Planque N; Leleu D; Bailly M; Caillet-Boudin ML; Saule S; Michalski JC
J Cell Biochem; 2002; 85(1):208-18. PubMed ID: 11891864
[TBL] [Abstract][Full Text] [Related]
51. O-GlcNAcylation of the Plum pox virus capsid protein catalyzed by SECRET AGENT: characterization of O-GlcNAc sites by electron transfer dissociation mass spectrometry.
Kim YC; Udeshi ND; Balsbaugh JL; Shabanowitz J; Hunt DF; Olszewski NE
Amino Acids; 2011 Mar; 40(3):869-76. PubMed ID: 20676902
[TBL] [Abstract][Full Text] [Related]
52. New ELISA-based method for the detection of O-GlcNAc transferase activity in vitro.
Qi J; Wang R; Zeng Y; Yu W; Gu Y
Prep Biochem Biotechnol; 2017 Aug; 47(7):699-702. PubMed ID: 28296566
[TBL] [Abstract][Full Text] [Related]
53. A monoclonal antibody against a family of nuclear pore proteins (nucleoporins): O-linked N-acetylglucosamine is part of the immunodeterminant.
Park MK; D'Onofrio M; Willingham MC; Hanover JA
Proc Natl Acad Sci U S A; 1987 Sep; 84(18):6462-6. PubMed ID: 2442757
[TBL] [Abstract][Full Text] [Related]
54. Detecting O-GlcNAc using in vitro sulfation.
Wu ZL; Robey MT; Tatge T; Lin C; Leymarie N; Zou Y; Zaia J
Glycobiology; 2014 Aug; 24(8):740-7. PubMed ID: 24799377
[TBL] [Abstract][Full Text] [Related]
55. O-glycosylation of serum IgD in IgA nephropathy.
Smith AC; de Wolff JF; Molyneux K; Feehally J; Barratt J
J Am Soc Nephrol; 2006 Apr; 17(4):1192-9. PubMed ID: 16510764
[TBL] [Abstract][Full Text] [Related]
56. Functional nuclear pores reconstituted with beta 1-4 galactose-modified O-linked N-acetylglucosamine glycoproteins.
Miller MW; Hanover JA
J Biol Chem; 1994 Mar; 269(12):9289-97. PubMed ID: 8132666
[TBL] [Abstract][Full Text] [Related]
57. Elevation of the post-translational modification of proteins by O-linked N-acetylglucosamine leads to deterioration of the glucose-stimulated insulin secretion in the pancreas of diabetic Goto-Kakizaki rats.
Akimoto Y; Hart GW; Wells L; Vosseller K; Yamamoto K; Munetomo E; Ohara-Imaizumi M; Nishiwaki C; Nagamatsu S; Hirano H; Kawakami H
Glycobiology; 2007 Feb; 17(2):127-40. PubMed ID: 17095531
[TBL] [Abstract][Full Text] [Related]
58. O-GlcNAc modification affects the ATM-mediated DNA damage response.
Miura Y; Sakurai Y; Endo T
Biochim Biophys Acta; 2012 Oct; 1820(10):1678-85. PubMed ID: 22759405
[TBL] [Abstract][Full Text] [Related]
59. AANL (Agrocybe aegerita lectin 2) is a new facile tool to probe for O-GlcNAcylation.
Liu W; Han G; Yin Y; Jiang S; Yu G; Yang Q; Yu W; Ye X; Su Y; Yang Y; Hart GW; Sun H
Glycobiology; 2018 Jun; 28(6):363-373. PubMed ID: 29562282
[TBL] [Abstract][Full Text] [Related]
60. IgA nephropathy caused by unusual polymerization of IgA1 with aberrant N-glycosylation in a patient with monoclonal immunoglobulin deposition disease.
Narimatsu Y; Kuno A; Ito H; Kaji H; Kaneko S; Usui J; Yamagata K; Narimatsu H
PLoS One; 2014; 9(3):e91079. PubMed ID: 24651839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
